Newsletter | March 25, 2026

03.25.26 -- Benchmarking RNA Delivery Performance: Toward Standardized Metrics For Translational Success

SPONSOR

Join Advancing RNA Chief Editor Anna Rose Welch on March 26 at 11 am ET for Advancements in gRNA Manufacturing & Quality. In this discussion with our knowledgeable panelists, we’ll dig into where the biggest gaps remain in our understanding of guide RNA quality and what improvements to the analytical toolbox/manufacturing paradigm need to be made to improve the overall understanding and quality of guide RNA. Register for free today.

FEATURED EDITORIAL

mRNA Hot Takes: Habaneros & Headwinds

Welcome to episode 4 of Advancing RNA’s mRNA Hot Takes, where we talk about serious RNA things with a spicy twist. ARW is joined by Radar Therapeutics' Sophia Lugo, Entrée Bio's Michelle Lynn Hall, & Sunrise BioVentures' Andrew Fraley to discuss the industry's biggest missteps and their impacts thus far. Other topics include the CMC morass, dealmaking nuances, educational initiatives, and more!

Why Standardized Benchmarking Is Essential In RNA Delivery Performance

As RNA pipelines mature, delivery success demands shared benchmarks. This article proposes standardized, stage-specific metrics to compare platforms, guide optimization, and build regulatory confidence.

The Hidden Physics Of RNA-LNPs: Tuning RNA Encapsulation For Potency

Why do LNPs that look identical behave differently in cells? This piece reveals how mixing physics and payload uniformity shape RNA potency, safety, dosing, and manufacturability—beyond size alone.

Primates, Patents, And Progress: Advancements In Rational LNP Design

In this opening Advancing RNA Live clip, NanoVation Therapeutics’ Dominik Witzigmann and Stealth Co’s John Zuris share the scientific advancements they’ve been watching most keenly in the LNP space, as well as some of the evolutions they’re seeing in the overall quality of our RNA-LNP products.

INDUSTRY INSIGHTS

Protecting Product Integrity Through Cold Chain

Temperature‑controlled storage, monitoring, and safeguards keep sensitive materials stable from fill to patient, protecting quality, preventing degradation, and ensuring safety throughout the cold chain.

Laminar And Turbulent Mixing Techniques For LNP Formulations Scale Up

Survey the critical factors in scaling up lipid nanoparticle (LNP) formulation, comparing the advantages and limitations of both laminar (microfluidic) and turbulent (tee and jet) mixing technologies.

dsRNA: Why Polymerase Choice Matters

Polymerase selection during IVT shapes dsRNA levels, processing costs, and product quality. See how enzyme engineering reduces abortive transcripts and improves purity profiles for complex mRNA manufacturing applications.

mRNA Process And Cost Modeling: A Tool To Optimize Process Development

Demand for mRNA-based medicine production continues to increase, as do investments in prophylactic and therapeutic indications. Explore a cost-model that compares all modalities.

How To Bring (Any) mRNA To Life: Simplifying Nucleic Acid Encapsulation

New technologies for nucleic acid encapsulation could overcome limitations of current standard mixing technologies. Review results of comparative studies and consider the benefits for your process.

Enhancing Safety And Efficacy Of mRNA-Based Therapeutics

Examine the challenges of dsRNA in mRNA therapeutic safety and how this RNA polymerase optimizes mRNA yield while reducing dsRNA byproducts for safer, more effective therapeutics.

Lipid Nanoparticles Boost CRISPR HDR Gene Insertion In Human T Cells

Lipid nanoparticles enable precise, non-viral gene editing in T cells to achieve high HDR efficiency and viability in scalable workflows. See how this approach overcomes viral vector limitations.

SPONSOR

The Alliance for mRNA Medicines and US Pharmacopeia invites you to attend a two-day workshop, End-to-End Analytical Solutions for mRNA Therapeutics: Supporting Manufacturing and CMC Needs, on April 14-15. Join leading scientists and regulatory stakeholders to explore critical aspects of Chemistry, Manufacturing, and Controls for mRNA-based products, with sessions featuring cutting-edge analytical methods, platform technologies, and emerging applications. Register here to attend in-person or virtually.

SOLUTIONS

Oligonucleotide Synthesis Solutions

Comprehensive mRNA Solutions

A CRO Accelerating Bioanalysis